CLPTM1L and ovarian cancer: For example, CLPTM1L, as a predicted transmembrane protein, is upregulated in cisplatin-resistant ovarian cancer cell lines, and may be involved in the apoptotic response of cells to cisplatin-induced genotoxic stress.